Lidothol Es System
Product Images NDC 80425-0561

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lidothol Es (NDC 80425-0561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine (Asset 1)

Chemical structure diagram showing the molecular formula of a compound containing aromatic rings, methyl groups, amide, and diethylamino groups. The structure likely represents the active ingredient related to the product, though the exact name is not shown in the image.*

FDA Label Image

Menthol (Asset 2)

Chemical structure diagram of the active ingredient menthol, showing a cyclohexane ring with hydroxyl group and methyl substituents.*

FDA Label Image

Figure1 (Asset 3)

A line graph showing plasma lidocaine concentration (ng/mL) over time (hours) from 0 to 72 hours. The concentration peaks approximately every 24 hours, indicating a repeating pattern of lidocaine plasma levels after administration. The y-axis ranges from 0 to about 130 ng/mL, and the x-axis covers a 72-hour period.*

FDA Label Image

Figure2 (Asset 4)

Chemical structure diagram illustrating the proposed metabolic pathway of menthol, showing its conversion into various metabolites including O-glucuronide, para-Menthane-3,7-diol, para-Menthane-3,9-diol, para-Menthane-3,8-diol, menthol-9-carboxylic acid, and 3,8-Dihydro-para-menthane-7-carboxylic acid. The diagram also indicates the enterophepatic circulation and routes of excretion via urine and feces.*

FDA Label Image

Lidothol Es Kit (Lidothol Es)

Lidothol ES Patch packaging label showing the product name with strengths menthol 5% and lidocaine 4%, dosage form as transdermal system. Label includes NDC 80425-0561-01, lot number, expiration date 12/31/2028, and manufacturer Advanced Rx of Tennessee, LLC, located in Nashville, TN. The label features storage instructions and a barcode.*

FDA Label Image

Di Table (Di Table)

A data table listing drug classes alongside specific examples of drugs within each class. Categories include nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs, each followed by examples such as nitroglycerin, lidocaine, cyclophosphamide, dapsone, chloroquine, phenytoin, and acetaminophen.*

FDA Label Image

Table1 (Table1)

A data table titled 'Absorption of Lidocaine from Lidocaine 5% Patch' showing results from normal volunteers wearing the patch for 12 hours. It details the application of three 5% patches (2100 mg) on the back with a 420 cm² area, listing average dose absorbed (64 ± 32 mg), plasma concentration (0.13 ± 0.06 µg/mL), and time (11 hours).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.